IQVIA, known across the life sciences industry for its clinical research operations, commercial analytics, and health-data expertise, has entered a strategic collaboration with Amazon Web Services (AWS), naming AWS as its Preferred Agentic Cloud Provider. Announced during AWS re:Invent, the partnership supports the rollout of IQVIA’s next-generation agentic AI platform, which is intended to accelerate automation in clinical trial execution, medical affairs workflows and healthcare analytics.
Under the agreement, IQVIA will deploy its agentic AI platform on AWS to support scalable and secure automation across trial processes and related activities. The companies also expect to look at new options in life science analytics, aiming to help customers draw out clearer data insights and make decisions with less friction. IQVIA said the collaboration is designed to improve clinical trial automation and shorten development timelines, while expanding the use of agentic AI in areas such as medical affairs and real-world evidence.
Both firms note that 90% of the world’s largest pharmaceutical companies already rely on IQVIA and AWS for digital transformation and analytics capabilities. By naming AWS as its Preferred Agentic Cloud Provider, IQVIA says it wants to make its AI tools more accessible and help life sciences organizations speed drug development and sharpen day-to-day operations.
“We are excited to move forward with AWS as IQVIA’s Preferred Agentic Cloud Provider. Our AI platform aims to empower life sciences organizations to innovate faster and deliver treatments to patients more efficiently,” said Lucas Glass, SVP, Architecture and Standards at IQVIA. “With agentic AI, we will unlock new possibilities for our clients and the industry at large.”
AWS emphasized the role that collaboration could play in advancing innovation across healthcare. “We are thrilled to support IQVIA’s Agentic AI platform with the full breadth of AWS’s cloud capabilities,” said Allyson Fryhoff, Director of Global Healthcare and Life Sciences at Amazon Web Services. “Together, we aim to help the life sciences industry leverage the power of AI to support ongoing innovation in healthcare and achieve outcomes once thought impossible.”
IQVIA and AWS describe the partnership as a step toward a broader wave of adoption, with the agentic AI platform expected to improve efficiency, speed research, and help bring new treatments to patients more quickly.
